A Phase 1, Multicenter, Randomized, Double-blind, Sequential Cohort, Placebo-controlled Trial to Assess the Safety and Tolerability of Ascending Multiple Oral Doses of Brexpiprazole as Adjunctive Therapy in the Treatment of Elderly Subjects With Major Depressive Disorder
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Brexpiprazole (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions; Therapeutic Use
- 03 Apr 2013 Planned End Date changed from 1 Feb 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov record.
- 30 Aug 2012 New trial record